In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Bluebird bio Inc (NASDAQ: BLUE) closed the day trading at $3.29 down -6.00% from the previous closing price of $3.50. In other words, the price has decreased by -$6.00 from its previous closing price. On the day, 2.9 million shares were traded.
Ratios:
For a better understanding of BLUE, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.28 and its Current Ratio is at 0.48.
BofA Securities Downgraded its Buy to Neutral on November 15, 2024, whereas the target price for the stock was revised from $3 to $0.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 03 ’25 when Colvin Richard A sold 584 shares for $3.92 per share. The transaction valued at 2,289 led to the insider holds 7,610 shares of the business.
Klima Thomas J sold 500 shares of BLUE for $1,960 on Mar 03 ’25. The insider now owns 7,878 shares after completing the transaction at $3.92 per share. On Mar 03 ’25, another insider, Obenshain Andrew, who serves as the President and CEO of the company, sold 921 shares for $3.92 each. As a result, the insider received 3,610 and left with 18,327 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.38.
Stock Price History:
Over the past 52 weeks, BLUE has reached a high of $28.60, while it has fallen to a 52-week low of $3.48. The 50-Day Moving Average of the stock is -20.89%, while the 200-Day Moving Average is calculated to be -62.08%.
Shares Statistics:
A total of 9.73M shares are outstanding, with a floating share count of 9.68M. Insiders hold about 1.08% of the company’s shares, while institutions hold 30.44% stake in the company.
